tiprankstipranks
Advertisement
Advertisement
Niagen Bioscience price target lowered to $12 from $13 at Roth Capital
PremiumThe FlyNiagen Bioscience price target lowered to $12 from $13 at Roth Capital
2M ago
Niagen Bioscience reports Q1 EPS 7c, consensus 6c
Premium
The Fly
Niagen Bioscience reports Q1 EPS 7c, consensus 6c
2M ago
Niagen Bioscience sees 2026 sales growth 10%-15%
Premium
The Fly
Niagen Bioscience sees 2026 sales growth 10%-15%
2M ago
Niagen Bioscience announces new partnership with Olympia Pharmaceuticals
PremiumThe FlyNiagen Bioscience announces new partnership with Olympia Pharmaceuticals
2M ago
Niagen Bioscience announces new partnership with Olympia Pharmaceuticals
Premium
The Fly
Niagen Bioscience announces new partnership with Olympia Pharmaceuticals
2M ago
Niagen Bioscience collaborates with USP to establish USP monograph
Premium
The Fly
Niagen Bioscience collaborates with USP to establish USP monograph
3M ago
Niagen Bioscience price target lowered to $13 from $14 at Canaccord
PremiumThe FlyNiagen Bioscience price target lowered to $13 from $14 at Canaccord
4M ago
Niagen Bioscience: Tru Niagen‑Driven Beat, Durable Double‑Digit Growth Outlook, and FDA Litigation Upside Support Buy Rating
Premium
Ratings
Niagen Bioscience: Tru Niagen‑Driven Beat, Durable Double‑Digit Growth Outlook, and FDA Litigation Upside Support Buy Rating
4M ago
Niagen Bioscience Reports Strong 2025 Results, Strategic Shift
Premium
Company Announcements
Niagen Bioscience Reports Strong 2025 Results, Strategic Shift
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100